Polynovo Limited Stock Performance
| CALZF Stock | USD 0.75 0.09 10.71% |
The company holds a Beta of 0.98, which implies possible diversification benefits within a given portfolio. PolyNovo returns are very sensitive to returns on the market. As the market goes up or down, PolyNovo is expected to follow. At this point, PolyNovo Limited has a negative expected return of -0.3%. Please make sure to check PolyNovo's standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to decide if PolyNovo Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days PolyNovo Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 7.7 M | |
| Total Cashflows From Investing Activities | 5.9 M |
PolyNovo |
PolyNovo Relative Risk vs. Return Landscape
If you would invest 94.00 in PolyNovo Limited on September 28, 2025 and sell it today you would lose (19.00) from holding PolyNovo Limited or give up 20.21% of portfolio value over 90 days. PolyNovo Limited is currently producing negative expected returns and takes up 3.3507% volatility of returns over 90 trading days. Put another way, 30% of traded pink sheets are less volatile than PolyNovo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
PolyNovo Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PolyNovo's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as PolyNovo Limited, and traders can use it to determine the average amount a PolyNovo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.09
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CALZF |
Based on monthly moving average PolyNovo is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PolyNovo by adding PolyNovo to a well-diversified portfolio.
PolyNovo Fundamentals Growth
PolyNovo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of PolyNovo, and PolyNovo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PolyNovo Pink Sheet performance.
| Return On Equity | -0.0595 | |||
| Return On Asset | 0.0092 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 954.45 M | |||
| Shares Outstanding | 688 M | |||
| Price To Book | 79.32 X | |||
| Price To Sales | 26.17 X | |||
| Revenue | 41.44 M | |||
| EBITDA | 753.46 K | |||
| Cash And Equivalents | 6.15 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.8 M | |||
| Debt To Equity | 0.62 % | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (2.06 M) | |||
| Total Asset | 34.97 M | |||
| Retained Earnings | (92 M) | |||
| Current Asset | 12 M | |||
| Current Liabilities | 1000 K | |||
About PolyNovo Performance
By analyzing PolyNovo's fundamental ratios, stakeholders can gain valuable insights into PolyNovo's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PolyNovo has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PolyNovo has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia. Calzada operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 152 people.Things to note about PolyNovo Limited performance evaluation
Checking the ongoing alerts about PolyNovo for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for PolyNovo Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PolyNovo Limited generated a negative expected return over the last 90 days | |
| PolyNovo Limited has some characteristics of a very speculative penny stock | |
| PolyNovo Limited has high historical volatility and very poor performance | |
| The company reported the revenue of 41.44 M. Net Loss for the year was (1.19 M) with profit before overhead, payroll, taxes, and interest of 33.94 M. | |
| PolyNovo Limited has accumulated about 6.15 M in cash with (2.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 17.0% of the company shares are held by company insiders |
- Analyzing PolyNovo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PolyNovo's stock is overvalued or undervalued compared to its peers.
- Examining PolyNovo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PolyNovo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PolyNovo's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PolyNovo's pink sheet. These opinions can provide insight into PolyNovo's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PolyNovo Pink Sheet analysis
When running PolyNovo's price analysis, check to measure PolyNovo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyNovo is operating at the current time. Most of PolyNovo's value examination focuses on studying past and present price action to predict the probability of PolyNovo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyNovo's price. Additionally, you may evaluate how the addition of PolyNovo to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |